Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca announces top-line phase III results from naloxegol pivotal trials in patients with opioid-induced constipation
-
Alzheimer’s, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration
-
AstraZeneca announces details of Chief Executive Officer Pascal Soriot's remuneration
-
AstraZeneca PLC Third quarter and nine months results 2012
-
AstraZeneca and Ironwood announce linaclotide collaboration for China
-
AstraZeneca and Ardelyx announce worldwide licensing deal for NHE3 inhibitor programme for complications of renal disease, including diabetes-induced renal disease
-
AstraZeneca suspends share repurchase programme, Core EPS target in the range of $6.00 and $6.30 unchanged
-
AstraZeneca prices a $2 billion bond issue
-
Pascal Soriot appointed Chief Executive Officer of AstraZeneca
-
European Commission approves ZINFORO™ (ceftaroline fosamil) for adult patients with serious skin infections or community acquired pneumonia
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
